Xeomin vs. Botox: What Is the Difference?

Both products reduce the nerve signal that tells a targeted muscle to contract. With less repeated movement, dynamic wrinkles soften. They do not add volume or permanently stop a muscle from working.

Xeomin vs. Botox at a Glance

*Standard Torrance pricing listed September 2026. Bundles and introductory offers may differ. Botulinum toxin potency units are product-specific and are not universally interchangeable between brands.

Do Xeomin and Botox Work the Same Way?

They act on the same basic pathway. Both are botulinum toxin type A products that reduce acetylcholine release at the neuromuscular junction. That lowers contraction in the selected muscle for a limited period.

Technique matters greatly. Dose, injection placement, muscle strength, brow position and facial anatomy can influence the result as much as the brand name.

What Is the Formulation Difference?

Xeomin contains incobotulinumtoxinA without accessory complexing proteins. Botox Cosmetic contains onabotulinumtoxinA as a botulinum toxin type A complex.

This is a real formulation difference, but it is often exaggerated online. Xeomin is sometimes called a “naked toxin.” That phrase can make it sound as though the vial contains nothing else, which is not accurate. Its finished formulation also includes inactive ingredients.

Which Areas Are FDA-Approved?

This is the biggest update the old article needs. Current Xeomin prescribing information includes moderate to severe glabellar lines, horizontal forehead lines and lateral canthal lines in adults. When all three upper-face areas are treated together, the labeled maximum dose is 64 units.

Botox Cosmetic is also FDA-approved for those three upper-face areas. In addition, Botox Cosmetic is FDA-approved for moderate to severe platysma bands in adults.

Other cosmetic uses can be off-label. Off-label treatment can be medically appropriate, but it should not be presented as an FDA-approved indication.

Does One Work Better?

There is no sound basis for naming one product the better choice for everyone.

A randomized, double-blind trial of 250 women compared 20 units of Xeomin with 20 units of Botox for moderate to severe glabellar lines. At one month, the treatments met the study’s predefined standard for equivalence. Improvement and patient satisfaction were similar through four months.

Some smaller studies have found differences at selected time points. That is why one study should not be turned into a universal ranking. Overall, both products have evidence supporting effective wrinkle reduction when used appropriately.

Does Botox Work Faster Than Xeomin?

Not reliably enough to promise a brand advantage.

The old article listed Botox onset as 2 to 3 days and Xeomin as 3 to 4 days. That makes the difference sound more certain than the evidence supports. Both can begin changing muscle activity within several days, and the full cosmetic result is judged later.

If you have an important event, it is safer to allow enough time for the treatment to settle than to choose a product based on a claimed one-day difference in onset.

Does Botox Last Longer Than Xeomin?

There is no dependable rule that Botox always lasts longer. The direct 20-unit glabellar trial found similar efficacy through four months.

In practice, both are commonly discussed as treatments that last around 3 to 4 months. Some patients see movement return earlier or later. Dose, treatment area, muscle strength, injection technique and individual response all matter.

Are Xeomin and Botox Units the Same?

The current labels use the same numerical dose totals for several upper-face areas: 20 units for the glabella, 24 units for crow’s feet, and 40 units for forehead plus glabella.

But both labels warn that potency units are product-specific and cannot be universally converted into units of another botulinum toxin product. That point becomes especially important when comparing Botox or Xeomin with Dysport, Jeuveau and other neuromodulators.

For the wider category, see our neuromodulator comparison guide.

Is Xeomin Less Likely to Cause Resistance?

Because Xeomin lacks accessory complexing proteins, it has a lower total foreign-protein load. That has created interest in whether it may reduce antibody formation.

However, routine cosmetic patients should not be told that Xeomin has been proven to prevent resistance better than Botox. Clinically meaningful neutralizing-antibody failure is uncommon at cosmetic doses, and direct long-term comparative evidence is limited.

Which Costs Less at Skin Works?

At Skin Works Torrance, the September 2026 standard price list shows Xeomin at $11 per unit and Botox at $12.50 per unit. The list also includes a 100-unit Xeomin bundle for $895. Promotional and new-patient pricing may differ.

Price per unit should not be the only deciding factor. Treatment should begin with the muscles involved, your anatomy and the dose needed to reach the goal.

See current clinic details on our Botox page and Xeomin page.

How Should You Choose?

For many upper-face patients, either product can be reasonable. A provider may consider your prior response, treatment area, previous side effects, price, treatment history and personal preference.

If one product has worked consistently for you, there may be no reason to switch just because another is marketed as newer, purer or faster. If results have become less predictable, the right response is to reassess the dose, injection pattern, interval and product rather than assume the brand alone is the problem.

The injector’s understanding of anatomy is usually more important than a simplistic brand ranking.

Do They Have the Same Major Safety Warning?

Both carry the FDA boxed warning for possible distant spread of botulinum toxin effect. Symptoms can include generalized weakness, double vision, drooping eyelids, trouble speaking or swallowing, and breathing difficulty.

Frequently Asked Questions